Pharma Equity Group AS (OCSE:PEG) Debt-to-Asset : 0.66 (As of Sep. 2024)

Pharma Equity Group AS Debt-to-Asset Chart

Pharma Equity Group AS Annual Data
	Trend	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20	Dec21	Dec22	Dec23
Debt-to-Asset		Get a 7-Day Free Trial					0.02	0.17	0.30	0.32	0.37

Pharma Equity Group AS Quarterly Data
	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Asset	Get a 7-Day Free Trial															0.27	0.37	0.50	0.57	0.66

Competitive Comparison of Pharma Equity Group AS's Debt-to-Asset

For the Biotechnology subindustry, Pharma Equity Group AS's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Pharma Equity Group AS's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Pharma Equity Group AS's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Pharma Equity Group AS's Debt-to-Asset falls into.

Pharma Equity Group AS Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Pharma Equity Group AS's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Pharma Equity Group AS's Debt-to-Asset for the quarter that ended in Sep. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Equity Group AS  (OCSE:PEG) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Pharma Equity Group AS Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Pharma Equity Group AS's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Equity Group AS Business Description